title: Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
abstract: Galanin (Gal) as a neuropeptide with widespread distribution in the central nervous system may be involved in the mechanisms of vasopressin (AVP) and oxytocin (OT) release from the hypothalamo-neurohypophysial system. Vasopressin and oxytocin content in the hypothalamus and neurohypophysis as well as plasma level of both neurohormones were studied after galanin treatment in euhydrated and dehydrated rats. In not dehydrated rats intracerebroventricular (i.c.v.) injections of Gal did not affect the hypothalamic and neurohypophysial OT content, however, distinctly increased plasma OT concentration. In the same animals Gal diminished the hypothalamic AVP content but was without the effect on neurohypophysial AVP storage; plasma AVP level then raised. Galanin, administered i.c.v. to rats deprived of water, distinctly inhibited AVP and OT release from the hypothalamo-neurohypophysial system. Simultaneously, plasma AVP and OT level was significantly diminished after Gal treatment in dehydrated rats. These results suggest that modulatory effect of galanin on vasopressin and oxytocin release depends on the actual state of water metabolism. Gal acts as an inhibitory neuromodulator of AVP and OT secretion under conditions of the dehydration but stimulates this process in the state of equilibrated water metabolism.
authors.affiliation: Department of Pathophysiology, Medical University of Lodz, Poland. joannack@poczta.onet.pl
authors.forename: J
authors.initials: J
authors.lastname: Ciosek
authors.forename: A
authors.initials: A
authors.lastname: Cisowska
mesh_terms: D000818:Animals; D001834:Body Water / Q000378:metabolism; D003681:Dehydration / Q000378:metabolism* / Q000503:physiopathology; D004334:Drug Administration Schedule; D019004:Galanin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000378:metabolism; D007031:Hypothalamus / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D010121:Oxytocin / Q000187:drug effects / Q000378:metabolism*; D010904:Pituitary Gland, Posterior / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D017208:Rats, Wistar; D014667:Vasopressins / Q000187:drug effects / Q000378:metabolism*
chemical_list: D014667:Vasopressins; D010121:Oxytocin; D019004:Galanin